메뉴 건너뛰기




Volumn 76, Issue 8, 2015, Pages 546-552

Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantation

Author keywords

Antibody incompatible kidney transplantation; Antibody mediated rejection; HLA antibodies; HLA Class 1; HLA Class 2; Pregnancy; Transfusion

Indexed keywords

HLA ANTIBODY; ALLOANTIBODY; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

EID: 84949500056     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.06.013     Document Type: Article
Times cited : (36)

References (22)
  • 1
    • 3943093300 scopus 로고    scopus 로고
    • Consensus opinion from the antibody working group on the diagnosis, reporting and risk assessment for antibody-mediated rejection and desensitisation protocols
    • Montgomery R.A., Hardy M.A., Jordan S.C., et al. Consensus opinion from the antibody working group on the diagnosis, reporting and risk assessment for antibody-mediated rejection and desensitisation protocols. Transplantation 2004, 78:181-185.
    • (2004) Transplantation , vol.78 , pp. 181-185
    • Montgomery, R.A.1    Hardy, M.A.2    Jordan, S.C.3
  • 3
    • 65549101698 scopus 로고    scopus 로고
    • Rises and falls in donor specific and third party HLA antibody levels after antibody incompatible transplantation
    • Higgins R., Lowe D., Hathaway M., et al. Rises and falls in donor specific and third party HLA antibody levels after antibody incompatible transplantation. Transplantation 2009, 87:882-888.
    • (2009) Transplantation , vol.87 , pp. 882-888
    • Higgins, R.1    Lowe, D.2    Hathaway, M.3
  • 4
    • 0030898854 scopus 로고    scopus 로고
    • Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients
    • Bevan D.J., Carey B.S., Fallon M., Higgins R.M., Hendry B.M., Bewick M. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients. Transpl Proc 1997, 29:1448.
    • (1997) Transpl Proc , vol.29 , pp. 1448
    • Bevan, D.J.1    Carey, B.S.2    Fallon, M.3    Higgins, R.M.4    Hendry, B.M.5    Bewick, M.6
  • 6
    • 55949096202 scopus 로고    scopus 로고
    • Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation
    • Burns J.M., Cornell L.D., Perry D.K., et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008, 8:2684-2694.
    • (2008) Am J Transplant , vol.8 , pp. 2684-2694
    • Burns, J.M.1    Cornell, L.D.2    Perry, D.K.3
  • 7
    • 76949086210 scopus 로고    scopus 로고
    • Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation
    • Gloor J.M., Winters J.L., Cornell L.D., et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010, 10:582-589.
    • (2010) Am J Transplant , vol.10 , pp. 582-589
    • Gloor, J.M.1    Winters, J.L.2    Cornell, L.D.3
  • 8
    • 38449105912 scopus 로고    scopus 로고
    • Blood levels of donor-specific HLA antibodies after renal transplantation; resolution of rejection in the presence of circulating donor specific antibody
    • Higgins R., Hathaway M., Lowe D., et al. Blood levels of donor-specific HLA antibodies after renal transplantation; resolution of rejection in the presence of circulating donor specific antibody. Transplantation 2007, 84:876-882.
    • (2007) Transplantation , vol.84 , pp. 876-882
    • Higgins, R.1    Hathaway, M.2    Lowe, D.3
  • 9
    • 80054742066 scopus 로고    scopus 로고
    • HLA antibody incompatible renal transplantation: excellent medium term outcomes with negative cytotoxic crossmatch
    • Higgins R., Lowe D., Hathaway M., et al. HLA antibody incompatible renal transplantation: excellent medium term outcomes with negative cytotoxic crossmatch. Transplantation 2011, 92:900-906.
    • (2011) Transplantation , vol.92 , pp. 900-906
    • Higgins, R.1    Lowe, D.2    Hathaway, M.3
  • 10
    • 42549138892 scopus 로고    scopus 로고
    • Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
    • Gupta A., Iveson V., Varagunam M., Bodger S., Sinnott P., Thuraisingham R.C. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?. Transplantation 2008, 85:1200-1204.
    • (2008) Transplantation , vol.85 , pp. 1200-1204
    • Gupta, A.1    Iveson, V.2    Varagunam, M.3    Bodger, S.4    Sinnott, P.5    Thuraisingham, R.C.6
  • 11
    • 77955607610 scopus 로고    scopus 로고
    • Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation
    • Lefaucheur C., Loupy A., Hill G.S., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21:1398-1406.
    • (2010) J Am Soc Nephrol , vol.21 , pp. 1398-1406
    • Lefaucheur, C.1    Loupy, A.2    Hill, G.S.3
  • 12
    • 78650369432 scopus 로고    scopus 로고
    • Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes
    • Singh N., Djamali A., Lorentzen D., et al. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes. Transplantation 2010, 90:1079-1084.
    • (2010) Transplantation , vol.90 , pp. 1079-1084
    • Singh, N.1    Djamali, A.2    Lorentzen, D.3
  • 13
    • 77951245486 scopus 로고    scopus 로고
    • Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA antibodies
    • Bachler K., Amico P., Honger G., et al. Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA antibodies. Am J Transplant 2010, 10:1254-1262.
    • (2010) Am J Transplant , vol.10 , pp. 1254-1262
    • Bachler, K.1    Amico, P.2    Honger, G.3
  • 14
    • 79951972563 scopus 로고    scopus 로고
    • Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy
    • Willicombe M., Brookes P., Santos-Nunez E., et al. Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2011, 11:470-477.
    • (2011) Am J Transplant , vol.11 , pp. 470-477
    • Willicombe, M.1    Brookes, P.2    Santos-Nunez, E.3
  • 15
    • 70350135489 scopus 로고    scopus 로고
    • Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies
    • Loupy A., Suberbielle-Boissel C., Hill G.S., et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009, 9:2561-2570.
    • (2009) Am J Transplant , vol.9 , pp. 2561-2570
    • Loupy, A.1    Suberbielle-Boissel, C.2    Hill, G.S.3
  • 16
    • 84876336190 scopus 로고    scopus 로고
    • Significant IgG subclass heterogeneity in HLA-specific antibodies: implications for pathogenicity, prognosis, and the rejection response
    • Lowe D., Higgins R., Zehnder D., Briggs D.C. Significant IgG subclass heterogeneity in HLA-specific antibodies: implications for pathogenicity, prognosis, and the rejection response. Hum Immunol 2013, 74:666-672.
    • (2013) Hum Immunol , vol.74 , pp. 666-672
    • Lowe, D.1    Higgins, R.2    Zehnder, D.3    Briggs, D.C.4
  • 17
    • 0142089741 scopus 로고    scopus 로고
    • A multi-factor analysis of kidney regraft outcomes
    • Gjertson D.W. A multi-factor analysis of kidney regraft outcomes. Clin Transpl 2002, 335-349.
    • (2002) Clin Transpl , pp. 335-349
    • Gjertson, D.W.1
  • 19
    • 0032834911 scopus 로고    scopus 로고
    • Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?
    • Fuller A., Profaizer T., Roberts L., Fuller T.C. Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?. Transplantation 1999, 68:589-591.
    • (1999) Transplantation , vol.68 , pp. 589-591
    • Fuller, A.1    Profaizer, T.2    Roberts, L.3    Fuller, T.C.4
  • 20
    • 67649598558 scopus 로고    scopus 로고
    • Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome
    • Caskey F.J., Johnson R.J., Fuggle S.V., Start S., Pugh D., Dudley C.R. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome. Transplantation 2009 Jun, 15(87):1727-1732.
    • (2009) Transplantation , vol.15 , Issue.87 , pp. 1727-1732
    • Caskey, F.J.1    Johnson, R.J.2    Fuggle, S.V.3    Start, S.4    Pugh, D.5    Dudley, C.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.